Loading clinical trials...
Loading clinical trials...
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Conditions
Interventions
DES
Locations
72
United States
Thomas Hospital
Fairhope, Alabama, United States
Scottsdale Healthcare
Scottsdale, Arizona, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
Bakersfield Memorial Hospital
Bakersfield, California, United States
Mission Cardiovascular Research Institute (Washington Hospital)
Fremont, California, United States
Long Beach VA Medical Center
Long Beach, California, United States
Start Date
January 2, 2018
Primary Completion Date
July 17, 2020
Completion Date
March 8, 2023
Last Updated
March 23, 2023
NCT07436429
NCT07429227
NCT01311323
NCT06543082
NCT06535568
NCT07032389
Lead Sponsor
Svelte Medical Systems, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions